Phase III, multi-centre, randomised, double blind, Placebo-controlled study for treatment of juvenile ankylosing spondylitis (AS) with Adalimumab von Horneff, G, Fitter, S, Huppertz, HI, Foeldvari, I, Kuemmerle-Deschner, K, Kuester, R, Tzaribacev, N, Thon, A, Borte, M, Ganser, G, Trauzeddel, R, Minden, K

Volltext